Alpha 2.0
Login Register
» Articles » PMID: 15475318

Arginine-rich Cell-penetrating Peptides with Uncharged Antisense Oligomers

Overview
Journal Drug Discov Today
Specialty Pharmacology
Date 2004 Oct 12
PMID 15475318
Citations 7
Authors
Hong M Moulton
Jon D Moulton
Affiliations
Soon will be listed here.
Citing Articles

Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy.

Tripathi P, Arami H, Banga I, Gupta J, Gandhi S Oncotarget. 2019; 9(98):37252-37267.

PMID: 30647857 PMC: 6324683. DOI: 10.18632/oncotarget.26442.

Canonical and non-canonical barriers facing antimiR cancer therapeutics.

Cheng C, Saltzman W, Slack F Curr Med Chem. 2013; 20(29):3582-93.

PMID: 23745563 PMC: 3901840. DOI: 10.2174/0929867311320290004.

Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Zhang X, Eden H, Chen X J Control Release. 2011; 159(1):2-13.

PMID: 22056916 PMC: 3288222. DOI: 10.1016/j.jconrel.2011.10.023.

Enhanced inhibition of porcine reproductive and respiratory syndrome virus replication by combination of morpholino oligomers.

Han X, Fan S, Patel D, Zhang Y Antiviral Res. 2009; 82(1):59-66.

PMID: 19428596 PMC: 7114178. DOI: 10.1016/j.antiviral.2009.01.009.

Gene knockdowns in adult animals: PPMOs and vivo-morpholinos.

Moulton J, Jiang S Molecules. 2009; 14(3):1304-23.

PMID: 19325525 PMC: 6253989. DOI: 10.3390/molecules14031304.